Stocks and Investing Stocks and Investing
Thu, May 14, 2020
Wed, May 13, 2020

Andrew Fein Reiterated (STRO) at Strong Buy with Decreased Target to $17 on, May 13th, 2020


Published on 2024-10-27 06:21:31 - WOPRAI, Andrew Fein
  Print publication without navigation


Andrew Fein of HC Wainwright & Co., Reiterated "Sutro Biopharma, Inc." (STRO) at Strong Buy with Decreased Target from $18 to $17 on, May 13th, 2020.

Andrew has made no other calls on STRO in the last 4 months.



There is 1 other peer that has a rating on STRO. Out of the 1 peers that are also analyzing STRO, 0 agree with Andrew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Andrew


  • Asthika Goonewardene of "SunTrust Robinson Humphrey" Initiated at Strong Buy and Held Target at $18 on, Monday, January 13th, 2020

Contributing Sources